@phdthesis{Hartmann2012, author = {Hartmann, Fabian}, title = {Elektrooptische Transporteigenschaften und stochastisch aktivierte Prozesse Resonanter Tunneldioden}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-90876}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2012}, abstract = {Im Rahmen der vorliegenden Arbeit wurden elektrooptische Transporteigenschaften und stochastisch aktivierte Prozesse Resonanter Tunneldioden (RTDs) bei Raumtemperatur untersucht. Die RTDs wurden auf dem III-V Halbleitermaterialsystem AlGaAs/GaAs durch Molekularstrahlepitaxie, Elektronenstrahllithographie und trockenchemischen {\"A}tztechniken hergestellt. Im Bereich des negativen differentiellen Leitwerts konnte bistabi-les Schalten und hierbei stochastisch aktivierte Dynamik nichtlinearer Systeme untersucht werden. Die Fl{\"a}chenabh{\"a}ngigkeit der {\"A}tzrate konnte ausgenutzt werden, um RTDs mit einem Stamm und zwei Transport{\"a}sten zu realisieren, welche hinsichtlich ihrer optischen und elektrischen Eigenschaften untersucht wurden. Im ersten experimentellen Abschnitt 3.1 werden die elektrischen Transporteigenschaften Resonanter Tunneldioden bei Raum-temperatur und die Fl{\"a}chenabh{\"a}ngigkeit des koh{\"a}renten und nicht-koh{\"a}renten Elektronen-transports analysiert. Die Realisierung universeller logischer Gatter (NOR und NAND) und deren Rekonfigurierbarkeit durch einen externen Kontrollparameter wird in Abschnitt 3.2 gezeigt. In Abschnitt 3.3 wird die Lichtsensitivit{\"a}t Resonanter Tunneldioden als Photode-tektoren f{\"u}r den sichtbaren Wellenl{\"a}ngenbereich und in Abschnitt 3.4 f{\"u}r die Telekommu-nikationswellenl{\"a}nge bei λ = 1,3 µm demonstriert.}, subject = {Resonanz-Tunneldiode}, language = {de} } @article{PfenningKruegerJabeenetal.2022, author = {Pfenning, Andreas and Kr{\"u}ger, Sebastian and Jabeen, Fauzia and Worschech, Lukas and Hartmann, Fabian and H{\"o}fling, Sven}, title = {Single-photon counting with semiconductor resonant tunneling devices}, series = {Nanomaterials}, volume = {12}, journal = {Nanomaterials}, number = {14}, issn = {2079-4991}, doi = {10.3390/nano12142358}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-281922}, year = {2022}, abstract = {Optical quantum information science and technologies require the capability to generate, control, and detect single or multiple quanta of light. The need to detect individual photons has motivated the development of a variety of novel and refined single-photon detectors (SPDs) with enhanced detector performance. Superconducting nanowire single-photon detectors (SNSPDs) and single-photon avalanche diodes (SPADs) are the top-performer in this field, but alternative promising and innovative devices are emerging. In this review article, we discuss the current state-of-the-art of one such alternative device capable of single-photon counting: the resonant tunneling diode (RTD) single-photon detector. Due to their peculiar photodetection mechanism and current-voltage characteristic with a region of negative differential conductance, RTD single-photon detectors provide, theoretically, several advantages over conventional SPDs, such as an inherently deadtime-free photon-number resolution at elevated temperatures, while offering low dark counts, a low timing jitter, and multiple photon detection modes. This review article brings together our previous studies and current experimental results. We focus on the current limitations of RTD-SPDs and provide detailed design and parameter variations to be potentially employed in next-generation RTD-SPD to improve the figure of merits of these alternative single-photon counting devices. The single-photon detection capability of RTDs without quantum dots is shown.}, language = {en} } @article{PrietoGarciaHartmannReisslandetal.2022, author = {Prieto-Garcia, Cristian and Hartmann, Oliver and Reissland, Michaela and Braun, Fabian and Bozkurt, S{\"u}leyman and Pahor, Nikolett and Fuss, Carmina and Schirbel, Andreas and Sch{\"u}lein-V{\"o}lk, Christina and Buchberger, Alexander and Calzado Canale, Marco A. and Rosenfeldt, Mathias and Dikic, Ivan and M{\"u}nch, Christian and Diefenbacher, Markus E.}, title = {USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K}, series = {Molecular Oncology}, volume = {16}, journal = {Molecular Oncology}, number = {17}, doi = {10.1002/1878-0261.13217}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-312777}, pages = {3082-3106}, year = {2022}, abstract = {Oncogenic transformation of lung epithelial cells is a multistep process, frequently starting with the inactivation of tumour suppressors and subsequent development of activating mutations in proto-oncogenes, such as members of the PI3K or MAPK families. Cells undergoing transformation have to adjust to changes, including altered metabolic requirements. This is achieved, in part, by modulating the protein abundance of transcription factors. Here, we report that the ubiquitin carboxyl-terminal hydrolase 28 (USP28) enables oncogenic reprogramming by regulating the protein abundance of proto-oncogenes such as c-JUN, c-MYC, NOTCH and ∆NP63 at early stages of malignant transformation. USP28 levels are increased in cancer compared with in normal cells due to a feed-forward loop, driven by increased amounts of oncogenic transcription factors such as c-MYC and c-JUN. Irrespective of oncogenic driver, interference with USP28 abundance or activity suppresses growth and survival of transformed lung cells. Furthermore, inhibition of USP28 via a small-molecule inhibitor resets the proteome of transformed cells towards a 'premalignant' state, and its inhibition synergizes with clinically established compounds used to target EGFR\(^{L858R}\)-, BRAF\(^{V600E}\)- or PI3K\(^{H1047R}\)-driven tumour cells. Targeting USP28 protein abundance at an early stage via inhibition of its activity is therefore a feasible strategy for the treatment of early-stage lung tumours, and the observed synergism with current standard-of-care inhibitors holds the potential for improved targeting of established tumours.}, language = {en} } @article{Prieto‐GarciaHartmannReisslandetal.2020, author = {Prieto-Garcia, Cristian and Hartmann, Oliver and Reissland, Michaela and Braun, Fabian and Fischer, Thomas and Walz, Susanne and Sch{\"u}lein-V{\"o}lk, Christina and Eilers, Ursula and Ade, Carsten P. and Calzado, Marco A. and Orian, Amir and Maric, Hans M. and M{\"u}nch, Christian and Rosenfeldt, Mathias and Eilers, Martin and Diefenbacher, Markus E.}, title = {Maintaining protein stability of ∆Np63 via USP28 is required by squamous cancer cells}, series = {EMBO Molecular Medicine}, volume = {12}, journal = {EMBO Molecular Medicine}, number = {4}, doi = {10.15252/emmm.201911101}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-218303}, year = {2020}, abstract = {The transcription factor ∆Np63 is a master regulator of epithelial cell identity and essential for the survival of squamous cell carcinoma (SCC) of lung, head and neck, oesophagus, cervix and skin. Here, we report that the deubiquitylase USP28 stabilizes ∆Np63 and maintains elevated ∆NP63 levels in SCC by counteracting its proteasome-mediated degradation. Impaired USP28 activity, either genetically or pharmacologically, abrogates the transcriptional identity and suppresses growth and survival of human SCC cells. CRISPR/Cas9-engineered in vivo mouse models establish that endogenous USP28 is strictly required for both induction and maintenance of lung SCC. Our data strongly suggest that targeting ∆Np63 abundance via inhibition of USP28 is a promising strategy for the treatment of SCC tumours.}, language = {en} } @article{RothmayrGuarinCastroHartmannetal.2022, author = {Rothmayr, Florian and Guarin Castro, Edgar David and Hartmann, Fabian and Knebl, Georg and Schade, Anne and H{\"o}fling, Sven and Koeth, Johannes and Pfenning, Andreas and Worschech, Lukas and Lopez-Richard, Victor}, title = {Resonant tunneling diodes: mid-infrared sensing at room temperature}, series = {Nanomaterials}, volume = {12}, journal = {Nanomaterials}, number = {6}, issn = {2079-4991}, doi = {10.3390/nano12061024}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-267152}, year = {2022}, abstract = {Resonant tunneling diode photodetectors appear to be promising architectures with a simple design for mid-infrared sensing operations at room temperature. We fabricated resonant tunneling devices with GaInAsSb absorbers that allow operation in the 2-4 μm range with significant electrical responsivity of 0.97 A/W at 2004 nm to optical readout. This paper characterizes the photosensor response contrasting different operational regimes and offering a comprehensive theoretical analysis of the main physical ingredients that rule the sensor functionalities and affect its performance. We demonstrate how the drift, accumulation, and escape efficiencies of photogenerated carriers influence the electrostatic modulation of the sensor's electrical response and how they allow controlling the device's sensing abilities.}, language = {en} } @article{StephanTascilarYalcinMutluetal.2023, author = {Stephan, Marlene and Tascilar, Koray and Yalcin-Mutlu, Melek and Hagen, Melanie and Haschka, Judith and Reiser, Michaela and Hartmann, Fabian and Kleyer, Arnd and Hueber, Axel J. and Manger, Bernhard and Figueiredo, Camille and Cobra, Jayme Fogagnolo and Tony, Hans-Peter and Finzel, Stephanie and Kleinert, Stefan and Wendler, J{\"o}rg and Schuch, Florian and Ronneberger, Monika and Feuchtenberger, Martin and Fleck, Martin and Manger, Karin and Ochs, Wolfgang and Schmitt-Haendle, Matthias and Lorenz, Hannes Martin and N{\"u}sslein, Hubert and Alten, Rieke and Henes, Joerg and Kr{\"u}ger, Klaus and Schett, Georg and Rech, J{\"u}rgen}, title = {Physical function of RA patients tapering treatment — a post hoc analysis of the randomized controlled RETRO trial}, series = {Journal of Clinical Medicine}, volume = {12}, journal = {Journal of Clinical Medicine}, number = {11}, issn = {2077-0383}, doi = {10.3390/jcm12113723}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-319349}, year = {2023}, abstract = {Several studies have shown that tapering or stopping disease-modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis (RA) patients in sustained remission is feasible. However, tapering/stopping bears the risk of decline in physical function as some patients may relapse and face increased disease activity. Here, we analyzed the impact of tapering or stopping DMARD treatment on the physical function of RA patients. The study was a post hoc analysis of physical functional worsening for 282 patients with RA in sustained remission tapering and stopping DMARD treatment in the prospective randomized RETRO study. HAQ and DAS-28 scores were determined in baseline samples of patients continuing DMARD (arm 1), tapering their dose by 50\% (arm 2), or stopping after tapering (arm 3). Patients were followed over 1 year, and HAQ and DAS-28 scores were evaluated every 3 months. The effect of treatment reduction strategy on functional worsening was assessed in a recurrent-event Cox regression model with a study-group (control, taper, and taper/stop) as the predictor. Two-hundred and eighty-two patients were analyzed. In 58 patients, functional worsening was observed. The incidences suggest a higher probability of functional worsening in patients tapering and/or stopping DMARDs, which is likely due to higher relapse rates in these individuals. At the end of the study, however, functional worsening was similar among the groups. Point estimates and survival curves show that the decline in functionality according to HAQ after tapering or discontinuation of DMARDs in RA patients with stable remission is associated with recurrence, but not with an overall functional decline.}, language = {en} }